Cardiology

Serelaxin reduces in-hospital worsening heart failure

Serelaxin reduces the occurrence of in-hospital worsening heart failure by almost half in patients admitted for acute heart failure, according to the RELAX-AHF trial. The results were presented for the first time today at ...

Cardiology

New class of drug targets heart disease

(Edmonton) Researchers at the University of Alberta have developed a synthetic peptide that could be the first in a new class of drugs to treat heart disease, high blood pressure and diabetes.

Health

Japan firm says skin stain complaints top 7,000

Japanese cosmetics maker Kanebo said Monday the number of complaints about skin discolouring from using its whitening products has topped 7,000 from customers both at home and abroad.

page 1 from 2